( NASDAQ-NMS:CPIX )

News from Cumberland Pharmaceuticals Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 25, 2017, 08:00 ET Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX, 'Cumberland') and Clinigen Group plc (AIM:CLIN, 'Clinigen'), announced today the promotional launch...


Aug 08, 2017, 16:05 ET Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Aug 01, 2017, 16:15 ET Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2017 financial results after the market closes...


Jul 31, 2017, 08:15 ET Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


May 15, 2017, 16:05 ET Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


May 08, 2017, 16:05 ET Cumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2017 financial results after the market closes on...


Apr 26, 2017, 08:00 ET New Kristalose® Growth Driver Established Through Co-Promotion Agreement

Cumberland Pharmaceuticals (NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Poly Pharmaceuticals Inc., a privately-held U.S. specialty...


Mar 27, 2017, 16:15 ET Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the publication of a trial providing evidence that using Caldolor in multimodal pain...


Mar 07, 2017, 16:15 ET Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Feb 28, 2017, 16:15 ET Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2016 financial results after the...


Feb 07, 2017, 08:15 ET Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the publication of a multicenter clinical study demonstrating that Caldolor®...


Jan 30, 2017, 08:15 ET U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Jan 16, 2017, 08:15 ET Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased to announce the addition of Kenneth J. Krogulski, CFA to its Board of Directors. He is...


Jan 09, 2017, 09:30 ET Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect®

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global...


Nov 16, 2016, 08:00 ET Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products

Cumberland Pharmaceuticals (NASDAQ: CPIX), a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S....


Nov 01, 2016, 16:05 ET Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Oct 25, 2016, 16:05 ET Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2016 financial results after the market closes on...


Sep 26, 2016, 08:30 ET Cumberland Pharmaceuticals Launches Promotion Of Ethyol® In The United States For Oncology Patient Support

NASHVILLE, Tenn., Sept. 26, 2016 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), announced today that it has launched the U.S....


Sep 14, 2016, 16:05 ET Cumberland Pharmaceuticals Announces New Program To Develop Portaban™ For Portal Hypertension

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced the initiation of a new Phase II clinical program of Portaban™ for...


Aug 23, 2016, 16:05 ET Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


Aug 02, 2016, 16:05 ET Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


Jul 26, 2016, 16:05 ET Cumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release second quarter 2016 financial results after the market...


Jul 18, 2016, 09:00 ET Cumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for...


May 10, 2016, 16:05 ET Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results

 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today...


May 10, 2016, 07:00 ET Cumberland Pharmaceuticals and Clinigen Group enter into exclusive U.S. commercialization agreement for oncology support drug Ethyol®

 Cumberland Pharmaceuticals Inc. ('Cumberland', NASDAQ: CPIX), a U.S. specialty pharmaceutical company and Clinigen Group plc ('Clinigen', AIM:...